Motion Sickness Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment Type (Anticholinergics, Antihistamines, Others); Distribution Channel (Retail Pharmacies, Online Pharmacies, Others)

Report Code: TIPRE00022327 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Motion sickness is characterized by a set of symptoms such as dizziness, nausea, and fatigue. It is commomly experienced by a person while traveling due to differences in impulses in the eyes, other body tissues, and sensory receptors. It is most commonly observed among children and geriatrics.

MARKET SCOPE

The "Global Motion Sickness Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Motion Sickness Drug market with detailed market segmentation by treatment type, distribution channel, and geography. The report provides key statistics on the market status of the leading motion sickness drug market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
  •   Based on treatment type, the global motion sickness drug market is segmented into Anticholinergics, Antihistamines, Others.
  •   On the basis of distribution channel, the market is segmented into retail pharmacies, online pharmacies, others.

MARKET DYNAMICS

Drivers-
  •   Increasing number of travellers.
  •   Rsising international toursim.
  •   Rise in adoption of prescription motion sickness drugs.
Restraints-
  •   Excessive dependency on traditional medicines
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Motion Sickness Drug market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Motion Sickness Drug market in these regions.

IMPACT OF COVID-19 ON MOTION SICKNESS DRUG MARKET

The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Tourism and hospitality businesses have been profoundly affected by COVID-19. International tourism has been highly affected due to travel bans on account of growing COVID-19 cases. Also, restrictions on travelling further affecting the demand of the market. Therefore, the COVID-19 has negatively impacted the growth if the motion sickness drug market.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Motion Sickness Drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Motion Sickness Drug market are anticipated to lucrative growth opportunities in the future with the rising demand for Motion Sickness Drug in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Motion Sickness Drug market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   GlaxoSmithKline plc
  •   Perrigo Company plc
  •   Prestige Consumer Healthcare Inc.
  •   WellSpring Pharmaceutical Corporation
  •   Caleb Pharmaceuticals Inc
  •   Myungmoon Pharm Co. Ltd
  •   Baxter International Inc
  •   CVS Health
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Motion Sickness Drug Market - By Treatment Type
1.3.2 Motion Sickness Drug Market - By Distribution Channel
1.3.3 Motion Sickness Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOTION SICKNESS DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MOTION SICKNESS DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MOTION SICKNESS DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. MOTION SICKNESS DRUG - GLOBAL MARKET OVERVIEW
6.2. MOTION SICKNESS DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MOTION SICKNESS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTICHOLINERGICS
7.3.1. Overview
7.3.2. Anticholinergics Market Forecast and Analysis
7.4. ANTIHISTAMINES
7.4.1. Overview
7.4.2. Antihistamines Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. MOTION SICKNESS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. RETAIL PHARMACIES
8.3.1. Overview
8.3.2. Retail Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Online Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. MOTION SICKNESS DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Motion Sickness Drug Market Overview
9.1.2 North America Motion Sickness Drug Market Forecasts and Analysis
9.1.3 North America Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Motion Sickness Drug Market
9.1.5.1.1 United States Motion Sickness Drug Market by Treatment Type
9.1.5.1.2 United States Motion Sickness Drug Market by Distribution Channel
9.1.5.2 Canada Motion Sickness Drug Market
9.1.5.2.1 Canada Motion Sickness Drug Market by Treatment Type
9.1.5.2.2 Canada Motion Sickness Drug Market by Distribution Channel
9.1.5.3 Mexico Motion Sickness Drug Market
9.1.5.3.1 Mexico Motion Sickness Drug Market by Treatment Type
9.1.5.3.2 Mexico Motion Sickness Drug Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Motion Sickness Drug Market Overview
9.2.2 Europe Motion Sickness Drug Market Forecasts and Analysis
9.2.3 Europe Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Motion Sickness Drug Market
9.2.5.1.1 Germany Motion Sickness Drug Market by Treatment Type
9.2.5.1.2 Germany Motion Sickness Drug Market by Distribution Channel
9.2.5.2 France Motion Sickness Drug Market
9.2.5.2.1 France Motion Sickness Drug Market by Treatment Type
9.2.5.2.2 France Motion Sickness Drug Market by Distribution Channel
9.2.5.3 Italy Motion Sickness Drug Market
9.2.5.3.1 Italy Motion Sickness Drug Market by Treatment Type
9.2.5.3.2 Italy Motion Sickness Drug Market by Distribution Channel
9.2.5.4 Spain Motion Sickness Drug Market
9.2.5.4.1 Spain Motion Sickness Drug Market by Treatment Type
9.2.5.4.2 Spain Motion Sickness Drug Market by Distribution Channel
9.2.5.5 United Kingdom Motion Sickness Drug Market
9.2.5.5.1 United Kingdom Motion Sickness Drug Market by Treatment Type
9.2.5.5.2 United Kingdom Motion Sickness Drug Market by Distribution Channel
9.2.5.6 Rest of Europe Motion Sickness Drug Market
9.2.5.6.1 Rest of Europe Motion Sickness Drug Market by Treatment Type
9.2.5.6.2 Rest of Europe Motion Sickness Drug Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Motion Sickness Drug Market Overview
9.3.2 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Motion Sickness Drug Market
9.3.5.1.1 Australia Motion Sickness Drug Market by Treatment Type
9.3.5.1.2 Australia Motion Sickness Drug Market by Distribution Channel
9.3.5.2 China Motion Sickness Drug Market
9.3.5.2.1 China Motion Sickness Drug Market by Treatment Type
9.3.5.2.2 China Motion Sickness Drug Market by Distribution Channel
9.3.5.3 India Motion Sickness Drug Market
9.3.5.3.1 India Motion Sickness Drug Market by Treatment Type
9.3.5.3.2 India Motion Sickness Drug Market by Distribution Channel
9.3.5.4 Japan Motion Sickness Drug Market
9.3.5.4.1 Japan Motion Sickness Drug Market by Treatment Type
9.3.5.4.2 Japan Motion Sickness Drug Market by Distribution Channel
9.3.5.5 South Korea Motion Sickness Drug Market
9.3.5.5.1 South Korea Motion Sickness Drug Market by Treatment Type
9.3.5.5.2 South Korea Motion Sickness Drug Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Motion Sickness Drug Market
9.3.5.6.1 Rest of Asia-Pacific Motion Sickness Drug Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Motion Sickness Drug Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Motion Sickness Drug Market Overview
9.4.2 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Motion Sickness Drug Market
9.4.5.1.1 South Africa Motion Sickness Drug Market by Treatment Type
9.4.5.1.2 South Africa Motion Sickness Drug Market by Distribution Channel
9.4.5.2 Saudi Arabia Motion Sickness Drug Market
9.4.5.2.1 Saudi Arabia Motion Sickness Drug Market by Treatment Type
9.4.5.2.2 Saudi Arabia Motion Sickness Drug Market by Distribution Channel
9.4.5.3 U.A.E Motion Sickness Drug Market
9.4.5.3.1 U.A.E Motion Sickness Drug Market by Treatment Type
9.4.5.3.2 U.A.E Motion Sickness Drug Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Motion Sickness Drug Market
9.4.5.4.1 Rest of Middle East and Africa Motion Sickness Drug Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Motion Sickness Drug Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Motion Sickness Drug Market Overview
9.5.2 South and Central America Motion Sickness Drug Market Forecasts and Analysis
9.5.3 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Motion Sickness Drug Market
9.5.5.1.1 Brazil Motion Sickness Drug Market by Treatment Type
9.5.5.1.2 Brazil Motion Sickness Drug Market by Distribution Channel
9.5.5.2 Argentina Motion Sickness Drug Market
9.5.5.2.1 Argentina Motion Sickness Drug Market by Treatment Type
9.5.5.2.2 Argentina Motion Sickness Drug Market by Distribution Channel
9.5.5.3 Rest of South and Central America Motion Sickness Drug Market
9.5.5.3.1 Rest of South and Central America Motion Sickness Drug Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Motion Sickness Drug Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MOTION SICKNESS DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MOTION SICKNESS DRUG MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PERRIGO COMPANY PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PRESTIGE CONSUMER HEALTHCARE INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. WELLSPRING PHARMACEUTICAL CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CALEB PHARMACEUTICALS INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYUNGMOON PHARM CO. LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BAXTER INTERNATIONAL INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CVS HEALTH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
The List of Companies

1. GlaxoSmithKline plc
2. Perrigo Company plc
3. Prestige Consumer Healthcare Inc.
4. WellSpring Pharmaceutical Corporation
5. Caleb Pharmaceuticals Inc
6. Myungmoon Pharm Co. Ltd
7. Baxter International Inc
8. CVS Health
TIPRE00022327
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking